Related Experiment Video
Updated: Jun 27, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study
John F Keaney1, Izabella Lipinska, Martin G Larson
1Evans Memorial Department of Medicine, Boston University School of Medicine, Boston, MA, USA. john.keaney@umassmed.edu
Insights
Soluble CD40 ligand (sCD40L) levels in blood are poorly linked to traditional cardiovascular disease risk factors. Genetic factors play a modest role, but more research is needed to understand sCD40L
Area of Science:
- Cardiovascular Science
- Immunology
- Genetics
Background:
- The CD40 receptor and its ligand (CD40L) influence inflammation and thrombosis, key factors in atherosclerosis.
- Elevated soluble CD40L (sCD40L) levels are associated with cardiovascular risk in specific patient groups.
Purpose of the Study:
- To identify predictors of sCD40L concentration in a large, community-based population.
- To investigate the relationship between sCD40L and established cardiovascular disease (CVD) risk factors.
Main Methods:
- Serum and plasma sCD40L concentrations were measured in 3,259 participants from the Framingham Offspring Study.
- Multivariable regression models were used to analyze predictors of sCD40L.
Main Results:
- Advancing age was the sole consistent inverse correlate of both serum and plasma sCD40L.
- Clinical covariates explained minimal variability in sCD40L (1.4% serum, 2.7% plasma).
- Genetic factors accounted for a modest portion of the adjusted variability in sCD40L (12% serum, 14% plasma).
Conclusions:
- Circulating sCD40L shows weak association with common CVD risk factors.
- sCD40L exhibits moderate heritability.
- Longitudinal studies are necessary to determine the predictive value of serum and plasma sCD40L for CVD risk in the general population.
Background:
The CD40 receptor and its ligand (CD40L) are known to modulate both inflammation and thrombosis-2 processes important for the development and clinical expression of atherosclerosis. Circulating soluble CD40L (sCD40L) concentration predicts cardiovascular risk in selected patient samples. The purpose of this study was to determine the predictors of sCD40L in a large, community-based sample.
Methods:
We determined both serum and plasma sCD40L concentration in 3,259 participants (54% women) from the Framingham Offspring Study.
Results:
In multivariable models, advancing age was the only consistent (inverse) correlate of both serum and plasma sCD40L concentration. Overall, the variability explained by clinical covariates was very low for both measurements of sCD40L; with values of only 1.4% and 2.7% for serum and plasma, respectively. We observed that genetic factors accounted for a modest (12% serum; 14% plasma) amount of the adjusted variability in sCD40L.
Conclusions:
Circulating sCD40L concentration was poorly associated with known cardiovascular disease (CVD) risk factors and was modestly heritable. Determining if either serum or plasma sCD40L are predictive of CVD risk in the community will require longitudinal follow-up.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Heritability
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
